Magnachip Q3 miss and weak Q4 guide reinforce wait-and-see stance

What happened

Magnachip's Q3 revenue of $45.9M came in below consensus, with gross margin of 18.6% missing its own forecast as a stronger Korean won and packaging constraints added to existing China pricing pressure. Management guided Q4 revenue to $38.5–42.5M and gross margin to just 8–10%, citing a $2.5M channel incentive and low fab utilization, which pushes the full-year margin to the low end. The call reiterated the shift toward differentiated power products but offered no evidence that new-generation products will exceed ~10% of revenue through 2026, leaving the mix-shift thesis unproven. Cash burn remains a concern, with operating cash flow of -$29.6M for the first nine months of 2025 and rising secured debt, even as the company holds $108M in cash. Taken together, the update confirms a still-degrading P&L and no near-term floor on revenue or margins, consistent with our WAIT rating.

Implication

Investors should treat the Q3 miss and weak Q4 guide as confirmation that restructuring costs, China pricing pressure, and FX headwinds are not yet offset by any mix improvement. The company's cash cushion and sub-book valuation provide some downside support, but ongoing losses, rising secured debt, and covenant sensitivity mean the balance sheet is not a reliable backstop. We would not add below $2.25 absent evidence of two consecutive quarters with revenue above $45M and gross margin above 18%, or a credible 2026 guidance implying revenue above $160M with gross margin recovery. Conversely, trimming above $4.00 remains prudent given the low probability of a near-term re-rating. Monitor the next two quarterly reports for signs that new-generation products are scaling above 10-15% of revenue and that opex cuts are materially reducing cash burn; until then, the risk/reward favors waiting.

Thesis delta

The latest earnings call does not change the core thesis but reinforces the bear-case probabilities. We maintain our WAIT rating and scenario probabilities, but note the quarter's margin miss and Q4 guide lean toward the lower end of our base case, increasing the likelihood that revenue and gross margin settle in the $38-42M range and mid-teens margin, respectively. The bull case remains dependent on unproven adoption of new-generation products, which management has not yet quantified beyond aspirational targets.